The University of Chicago Header Logo

Connection

Sandeep Gurbuxani to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Alemtuzumab.
Sandeep Gurbuxani
Connection Strength
0.035
Alemtuzumab
  1. CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review. J Gastrointest Cancer. 2007; 38(1):19-23.
    View in: PubMed
    Score: 0.018
  2. CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review. J Gastrointest Cancer. 2007; 38(1):59-62.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.